Press Releases View All

Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
January 6, 2025
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy
December 3, 2024

Presentations / Publications

Download Our Corporate Presentation Now View All

Product News and Investor Relations Announcements

Get Email Updates

Revolutionizing Nitric Oxide Therapy

See Active Pipeline